CompaniesGanymed Pharmaceuticals

Ganymed Pharmaceuticals

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (3)

Total Trials

3

As Lead Sponsor

3

As Collaborator

0

Total Enrollment

111

By Phase

PHASE1: 2PHASE2: 1

By Status

COMPLETED: 3

Clinical Trials Pipeline3 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2008

2009

2010

2011

2012

2013

2014

2015

2016

Today

Hover over trial bars to see details

Recent Trials

NCT02054351Lead Sponsor

Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR)

PHASE1Completed

42 participants

Started: Feb 6, 2014 · Completed: Oct 28, 2015

NCT01197885Lead Sponsor

Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer

PHASE2Completed

54 participants

Started: Sep 3, 2010 · Completed: Aug 13, 2015

NCT00909025Lead Sponsor

Safety and Tolerability Study of Claudiximab in Patients With Advanced Gastroesophageal Cancer

PHASE1Completed

15 participants

Started: May 31, 2009 · Completed: May 31, 2010

Ganymed Pharmaceuticals | Biotech Hunter | Biotech Hunter